Evidence map›Paper›PMID 29525848›Full record

ArticleBiological trace element research2018

Trace Elements and Paraoxonase-1 Activity in Lower Extremity Artery Disease.

Joaquim Rovira, Anna Hernández-Aguilera, Fedra Luciano-Mateo, Noemí Cabré, Gerard Baiges-Gaya, Martí Nadal, Vicente Martín-Paredero, Jordi Camps, Jorge Joven, José L Domingo

Abstract read
PubMed Publisher
In one paragraph

Article in Biological trace element research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. New Progress in Early Diagnosis of Atherosclerosis.International journal of molecular sciences · 2022
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Joaquim Rovira *Laboratory of Toxicology and Environmental Health, School of Medicine, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Sant Llorenç 21, 43201, Reus, Spain.
Anna Hernández-Aguilera *Unitat de Recerca Biomèdica, Hospital Universitari Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Carrer Sant Joan s/n, 43201, Reus, Spain.
Fedra Luciano-MateoUnitat de Recerca Biomèdica, Hospital Universitari Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Carrer Sant Joan s/n, 43201, Reus, Spain.
Noemí CabréUnitat de Recerca Biomèdica, Hospital Universitari Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Carrer Sant Joan s/n, 43201, Reus, Spain.
Gerard Baiges-GayaUnitat de Recerca Biomèdica, Hospital Universitari Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Carrer Sant Joan s/n, 43201, Reus, Spain.
Martí NadalLaboratory of Toxicology and Environmental Health, School of Medicine, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Sant Llorenç 21, 43201, Reus, Spain.
Vicente Martín-ParederoDepartment of Vascular Surgery, Hospital Universitari Joan XXIII, Tarragona, Spain.
Jordi CampsUnitat de Recerca Biomèdica, Hospital Universitari Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Carrer Sant Joan s/n, 43201, Reus, Spain. jcamps@grupsagessa.com.ORCID http://orcid.org/0000-0002-3165-3640
Jorge JovenUnitat de Recerca Biomèdica, Hospital Universitari Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Carrer Sant Joan s/n, 43201, Reus, Spain.
José L DomingoLaboratory of Toxicology and Environmental Health, School of Medicine, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Sant Llorenç 21, 43201, Reus, Spain.
Institut de Recerca Biomèdica Catalunya Sud · ESHospital Universitari Joan XXIII de Tarragona · ES

Funding

AGAUR 2014SGR1227Instituto de Investigación Sanitariaria Carlos III PI15/00285
6 · The paper itself

Abstract

Oxidative stress and inflammation are candidate mechanisms to explain the potential role of exposure to metals and reduced activity of paraoxonase-1 (PON1) in age-related diseases. Both may be risk factors contributing to atherosclerosis. In the present study, inductively coupled mass spectrometry was used to explore multiple trace elements, while in-house methods were employed to measure PON1-related variables in patients with lower extremity artery disease (LEAD). Healthy controls were matched for sex, age, body weight, and relevant genotype variants. Serum concentrations of As, Ba, Cu, and Sr were higher in patients than those in controls, with a strong predictive ability to discriminate between groups. Differences in serum Pb, Cd, and Zn were negligible. Serum Cu increased when the disease was more severe, but a negative trend was noted for serum As, B, Ba, and Zn. The only variable associated with ankle-brachial index was serum Zn. Serum PON1 activity was significantly lower in LEAD patients. When the ability of serum trace elements to modulate PON1 activity was explored, the analysis revealed a unique association with serum Zn. The current results strongly suggest that Zn may have a protective effect in non-coronary atherosclerosis and indicate that this element may exert its anti-inflammatory and antioxidant functions through interactions with PON1 activity. These findings deserve confirmation and further research. In particular, the periodic evaluation of serum trace elements and the prescription of Zn supplements are easy measures to implement and that can improve the treatment of patients with LEAD.

Indexed as

AgedAnti-Inflammatory Agents, Non-SteroidalAntioxidantsAryldialkylphosphataseAtherosclerosisFemaleHumansLower ExtremityMaleMass SpectrometryMiddle AgedTrace ElementsAnti-Inflammatory Agents, Non-SteroidalAntioxidantsAryldialkylphosphataseTrace ElementsInflammationLower extremity arterial diseaseOxidationVascular toxicityZinc

Identifiers

PMID29525848
OpenAlexW2789771991

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.